Inhibikase Therapeutics, Inc.
IKT- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001750149
No open-market purchases or sales by Inhibikase Therapeutics, Inc. insiders were filed in the last 90 days; 105 institutions reported holding it in 13F filings for Q2 2026, worth $239.2M in total; no superinvestor holds it.
13F holders, Q1 2025
Institutional positions in Inhibikase Therapeutics, Inc. as of Mar 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 47
- +16 vs. Q4 2024
- Shares held
- 51.5M
- +1.40M (+2.8%) vs. Q4 2024
- Total value
- $112.7M
- −$50.0M (−30.7%) vs. Q4 2024
- New holders
- 19
- 12 more added
- Sold out
- 3
- 3 more reduced
Compare with Q4 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting IKT on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 105 | $239.2M |
| Q1 2026 | 104 | $193.4M |
| Q4 2025 | 74 | $218.2M |
| Q3 2025 | 54 | $89.0M |
| Q2 2025 | 48 | $106.3M |
| Q1 2025 | 47 | $112.7M |
| Q4 2024 | 31 | $162.7M |
| Q3 2024 | 11 | $1.12M |
| Q2 2024 | 12 | $1.02M |
| Q1 2024 | 12 | $443.8K |
| Q4 2023 | 11 | $298.9K |
| Q3 2023 | 13 | $597.6K |
| Q2 2023 | 14 | $2.69M |
| Q1 2023 | 17 | $2.91M |
| Q4 2022 | 19 | $719.4K |
| Q3 2022 | 24 | $2.78M |
| Q2 2022 | 22 | $2.49M |
| Q1 2022 | 24 | $6.33M |
| Q4 2021 | 26 | $6.85M |
| Q3 2021 | 21 | $7.78M |
| Q2 2021 | 14 | $10.6M |
| Q1 2021 | 9 | $975.0K |
Institutions, Q1 2025
Shares, value and share of portfolio for each institution holding Inhibikase Therapeutics, Inc.; share changes are against Q4 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Sands Capital Ventures, LLC | 10,950,000 | $24.0M | 5.86% | 00.0% | Unchanged |
| Soleus Capital Management, L.P. | 6,325,000 | $13.9M | 1.09% | 00.0% | Unchanged |
| Fairmount Funds Management LLC | 6,125,000 | $13.4M | 2.08% | 00.0% | Unchanged |
| Perceptive Advisors LLC | 5,925,000 | $13.0M | 0.46% | 00.0% | Unchanged |
| Commodore Capital LP | 5,344,432 | $11.7M | 0.86% | −580,568−9.8% | Reduced |
| ADAR1 Capital Management, LLC | 5,122,105 | $11.2M | 2.16% | +19,100+0.4% | Added |
| Vanguard Group Inc | 2,848,663 | $6.24M | 0.00% | +10,018+0.4% | Added |
| Nantahala Capital Management, LLC | 2,190,000 | $4.80M | 0.40% | 00.0% | Unchanged |
| Blackstone Group Inc. | 2,070,684 | $4.53M | 0.02% | 00.0% | Unchanged |
| Stonepine Capital Management, LLC | 914,973 | $2.00M | 2.33% | −217,415−19.2% | Reduced |
| Millennium Management LLC | 913,502 | $2.00M | 0.00% | +771,293+542.4% | Added |
| Susquehanna International Group, LLP | 504,625 | $1.11M | 0.00% | +504,625 | New |
| BlackRock, Inc. | 423,979 | $928.5K | 0.00% | +88,519+26.4% | Added |
| Geode Capital Management, LLC | 324,760 | $711.3K | 0.00% | +1,882+0.6% | Added |
| Goldman Sachs Group Inc | 166,025 | $363.6K | 0.00% | +122,073+277.7% | Added |
| Blair William & Co | 155,953 | $341.5K | 0.00% | +21,000+15.6% | Added |
| Marshall Wace, LLP | 155,270 | $340.0K | 0.00% | +155,270 | New |
| Jane Street Group, LLC | 116,249 | $254.6K | 0.00% | +116,249 | New |
| Barclays PLC | 84,000 | $184.0K | 0.00% | 00.0% | Unchanged |
| Balyasny Asset Management LLC | 81,161 | $177.7K | 0.00% | +81,161 | New |
| HRT Financial LP | 65,906 | $144.0K | 0.00% | +19,490+42.0% | Added |
| Northern Trust Corp | 64,011 | $140.2K | 0.00% | 00.0% | Unchanged |
| Omers Administration Corp | 56,000 | $122.6K | 0.00% | +1,400+2.6% | Added |
| Jain Global LLC | 54,845 | $120.1K | 0.00% | +54,845 | New |
| UBS Group AG | 45,266 | $99.1K | 0.00% | +17,740+64.4% | Added |
| Bank of America Corp | 45,026 | $98.6K | 0.00% | +40,517+898.6% | Added |
| State Street Corp | 41,884 | $91.7K | 0.00% | 00.0% | Unchanged |
| Qube Research & Technologies Ltd | 35,625 | $78.0K | 0.00% | +35,625 | New |
| ExodusPoint Capital Management, LP | 32,538 | $71.0K | 0.00% | +32,538 | New |
| LMR Partners LLP | 31,092 | $68.1K | 0.00% | +31,092 | New |
| Diametric Capital, LP | 28,366 | $62.1K | 0.07% | +28,366 | New |
| Y-Intercept (Hong Kong) Ltd | 26,775 | $58.6K | 0.00% | +26,775 | New |
| Citigroup Inc | 25,765 | $56.4K | 0.00% | −51,335−66.6% | Reduced |
| Morgan Stanley | 21,646 | $47.4K | 0.00% | +14,350+196.7% | Added |
| Schonfeld Strategic Advisors LLC | 16,876 | $37.0K | 0.00% | +16,876 | New |
| Caxton Corp | 16,393 | $35.9K | 0.71% | 00.0% | Unchanged |
| Point72 Asia (Singapore) Pte. Ltd. | 14,976 | $32.8K | 0.01% | +14,976 | New |
| Jefferies Financial Group Inc. | 14,800 | $32.4K | 0.00% | 00.0% | Unchanged |
| Catalyst Funds Management Pty Ltd | 13,712 | $30.0K | 0.01% | +13,712 | New |
| Stifel Financial Corp | 13,129 | $28.8K | 0.00% | 00.0% | Unchanged |
| Quantessence Capital LLC | 13,005 | $28.5K | 0.01% | +13,005 | New |
| Prelude Capital Management, LLC | 11,098 | $24.3K | 0.00% | +11,098 | New |
| Capstone Investment Advisors, LLC | 11,067 | $24.2K | 0.00% | +11,067 | New |
| Brevan Howard Capital Management LP | 10,384 | $22.7K | 0.00% | +10,384 | New |
| Cubist Systematic Strategies, LLC | 9,043 | $19.8K | 0.00% | +9,043 | New |
| Point72 (DIFC) Ltd | 1,980 | $4.34K | 0.00% | +1,980 | New |
| Wells Fargo & Company | 167 | $366 | 0.00% | 00.0% | Unchanged |
| Squarepoint Ops LLC | 0 | $0 | 0.00% | −28,411−100.0% | Sold out |
| Alpine Global Management, LLC | 0 | $0 | 0.00% | −14,842−100.0% | Sold out |
| Synergy Financial Management, LLC | 0 | $0 | 0.00% | −50−100.0% | Sold out |